This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2000 Jan-Feb;7(1):81-4.

doi: 10.1067/mnc.2000.104276.

The role of cardiac imaging in optimizing therapy in heart failure

A Lahiri

PMID: 10698238
DOI: 10.1067/mnc.2000.104276

Editorial

The role of cardiac imaging in optimizing therapy in heart failure

A Lahiri. J Nucl Cardiol. 2000 Jan-Feb.

. 2000 Jan-Feb;7(1):81-4.

doi: 10.1067/mnc.2000.104276.

Author

A Lahiri

PMID: 10698238
DOI: 10.1067/mnc.2000.104276

No abstract available

PubMed Disclaimer

Comment on

Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure.
O'Keefe JH Jr, Magalski A, Stevens TL, Bresnahan DR Jr, Alaswad K, Krueger SK, Bateman TM. O'Keefe JH Jr, et al. J Nucl Cardiol. 2000 Jan-Feb;7(1):3-7. doi: 10.1067/mnc.2000.102678. J Nucl Cardiol. 2000. PMID: 10698228 Clinical Trial.

Similar articles

Re: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.
Lou YF, Shi XP, Tong H, Yu GY, Yao GD, Dong K. Lou YF, et al. Circ J. 2009 Dec;73(12):2363; author reply 2364. doi: 10.1253/circj.cj-09-73-1201. Circ J. 2009. PMID: 19940373 No abstract available.
Heart failure patients with B1-adrenoreceptor polymorphisms have augmented carvedilol response as detected by cardiac I123-MIBG scintigraphy.
Miranda SM, Moscavitch SD, Pereira SB, de Azevedo JC, Messias LR, Rodrigues RC, Mesquita ET, Ribeiro GS, Mesquita CT. Miranda SM, et al. Int J Cardiol. 2014 Nov 15;177(1):111-3. doi: 10.1016/j.ijcard.2014.09.064. Epub 2014 Sep 28. Int J Cardiol. 2014. PMID: 25499350 No abstract available.
Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol.
Gardner RS, McGowan J, McDonagh TA. Gardner RS, et al. Eur J Heart Fail. 2002 Jun;4(3):377-9. doi: 10.1016/s1388-9842(02)00012-0. Eur J Heart Fail. 2002. PMID: 12034165
Cardiac remodeling in coronary artery disease.
Sharpe N. Sharpe N. Am J Cardiol. 2004 May 6;93(9A):17B-20B. doi: 10.1016/j.amjcard.2004.01.002. Am J Cardiol. 2004. PMID: 15144932 Review.
Carvedilol for heart failure: renewed interest in beta blockers.
Young JB. Young JB. Cleve Clin J Med. 1997 Sep;64(8):415-22. doi: 10.3949/ccjm.64.8.415. Cleve Clin J Med. 1997. PMID: 9308217 Review.

See all similar articles

Cited by

Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease.
Sabharwal NK, Lahiri A. Sabharwal NK, et al. Heart. 2003 Nov;89(11):1291-7. doi: 10.1136/heart.89.11.1291. Heart. 2003. PMID: 14594881 Free PMC article. Review.

References

1. J Am Coll Cardiol. 1995 Nov 1;26(5):1376-98 - PubMed
1. J Am Coll Cardiol. 1999 Mar;33(3):759-66 - PubMed
1. N Engl J Med. 1991 Aug 1;325(5):303-10 - PubMed
1. J Am Coll Cardiol. 1999 Jun;33(7):1848-54 - PubMed
1. Circulation. 1996 Nov 1;94(9):2285-96 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information